Flebopress capsules 300mg, 60pcs

Composition

Composition for 1 capsule: Active ingredient: troxerutin-300,00 mg

Pharmacological action

Semi-synthetic bioflavonoid (rutin derivative) of the benzopyran class, has P-vitamin activity, has venotonizing, angioprotective, anti-inflammatory and anti-edematous effects, reduces capillary permeability and fragility. Its pharmacodynamic properties are associated with the involvement of the bioflavonoids troxerutin in redox processes and inhibition of hyaluronidase. By inhibiting hyaluronidase, troxerutin stabilizes the hyaluronic acid of cell membranes and reduces their permeability. It has antioxidant activity, as a result of which it prevents the oxidation of ascorbic acid, epinephrine and lipids. In addition, it reduces the permeability and fragility of capillaries, prevents damage to the basement membrane of endothelial cells when exposed to various factors. Troxerutin increases the density of the vascular wall, reduces the exudation of the liquid part of the plasma and blood cell diapedesis. Reduces exudative inflammation in the vascular wall, reducing platelet adhesion to its surface. Inhibits aggregation and increases the degree of deformation of red blood cells. The use of troxerutin is possible, both at the initial and late stages of treatment of chronic venous insufficiency, it can be used as one of the components of complex treatment. Troxerutin reduces swelling and heaviness in the legs, reduces the intensity of pain and cramps, and improves tissue trophism. Troxerutin relieves the symptoms associated with hemorrhoids (pain, exudation, itching, bleeding). Troxerutin helps slow the progression of diabetic retinopathy due to its effect on the permeability and resistance of capillary walls. The effect of troxerutin on the rheological properties of blood helps prevent the development of retinal vascular microthrombosis.

Indications

The drug Flebopress ® capsules 300 mg is used as part of the complex therapy of these diseases: • chronic venous insufficiency• * trophic disorders in chronic venous insufficiency and trophic ulcers;• varicose veins;• superficial thrombophlebitis, periflebitis;• post-thrombotic syndrome;• post-traumatic edema and soft tissue hematomas• * as an adjunct treatment after sclerotherapy and / or removal of varicose veins of the lower extremities;• hemorrhoids (to relieve symptoms•; * diabetic angiopathy, retinopathy.

Contraindications

* Hypersensitivity to troxerutin and other components of the drug; • Peptic ulcer of the stomach, duodenum, chronic gastritis in the acute phase • * Lactose intolerance, lactase deficiency or glucose-galactose malabsorption syndrome; * Pregnancy (I trimester); • Breast-feeding period; * Children under 18 years of age (limited experience)

How to take, course of use and dosage

Inside. Capsules should be swallowed whole, with a meal, with a sufficient amount of water. At the initial stage of treatment,1 capsule (300 mg) is prescribed 3 times a day. The effect usually develops within 2 weeks. Further, treatment is continued at the same dose or reduced to the average therapeutic dose-1 capsule 2 times a day (600 mg), or suspended (while the achieved effect persists for at least 4 weeks). If necessary, the dose can be increased after consulting your doctor. The average course of treatment is 3-4 weeks. For maintenance therapy, it is sufficient to take 1 capsule (300 mg) per day for 3 to 4 weeks. In diabetic retinopathy, Flebopress® is prescribed 2 capsules (a single dose of 600 mg) 3 times a day (a daily dose of 1.8 g). On average, the duration of the therapeutic course is 3-4 weeks. The need for longer treatment is determined after consultation with a doctor and individually.

Active ingredient

Troxerutin

Dosage form

Capsules